New Key Statistics Module, Z-Score and F-Score
NAS:RIGL Key Ratios
Market Cap $ M | 491.11 |
Enterprise Value $ M | 490.22 |
P/E(ttm) | 121.22 |
PE Ratio without NRI | 121.22 |
Forward PE Ratio | 28.51 |
Price/Book | -- |
Price/Sales | 3.11 |
Price/Free Cash Flow | 47.99 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 157.00 |
EPS (TTM) $ | 0.23 |
Beneish M-Score | -2.22 |
10-y EBITDA Growth Rate % | 21.00 |
5-y EBITDA Growth Rate % | 22.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 41.72 |
EV-to-EBITDA | 35.87 |
PEG | 5.32 |
Shares Outstanding M | 17.62 |
Net Margin (%) | 2.47 |
Operating Margin % | 6.04 |
Pre-tax Margin (%) | 2.47 |
Quick Ratio | 1.87 |
Current Ratio | 1.96 |
ROA % (ttm) | 3.10 |
ROE % (ttm) | 10,000.00 |
ROIC % (ttm) | 14.02 |
Dividend Yield % | -- |
Altman Z-Score | -10.33 |
RIGL Number of Guru Trades
RIGL Volume of Guru Trades
Gurus Latest Trades with NAS:RIGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RIGL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Rigel Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:RIGL
Total 0- 1